Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (281-290 of 333) with videos related to

Pageof 34
Sort By:
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2017
ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol LevelsLaia Trigueros-Motos, Julian C van Capelleveen, Federico Torta, et al.
European Heart Journal|May 3, 2018
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractFrançois Mach, Kausik K Ray, Olov Wiklund, et al.
Cardiovascular Drugs and Therapy|May 14, 2022
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCIAntonio J Vallejo-Vaz, Sarah Bray, Guillermo Villa, et al.
Archives of Medical Science : AMS|April 11, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Expert Opinion on Drug Safety|April 25, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
The New England Journal of Medicine|August 25, 2023
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and ObesityMikhail N Kosiborod, Steen Z Abildstrøm, Barry A Borlaug, et al.
Lancet (London, England)|April 10, 2024
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trialsJaved Butler, Sanjiv J Shah, Mark C Petrie, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
The New England Journal of Medicine|April 8, 2024
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 DiabetesMikhail N Kosiborod, Mark C Petrie, Barry A Borlaug, et al.
Pageof 34

Showing results (281-290 of 333) with videos related to

Sort By:
Pageof 34
European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 9, 2017
ABCA8 Regulates Cholesterol Efflux and High-Density Lipoprotein Cholesterol LevelsLaia Trigueros-Motos, Julian C van Capelleveen, Federico Torta, et al.
European Heart Journal|May 3, 2018
Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataractFrançois Mach, Kausik K Ray, Olov Wiklund, et al.
Cardiovascular Drugs and Therapy|May 14, 2022
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCIAntonio J Vallejo-Vaz, Sarah Bray, Guillermo Villa, et al.
Archives of Medical Science : AMS|April 11, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
Expert Opinion on Drug Safety|April 25, 2015
Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert PanelMaciej Banach, Manfredi Rizzo, Peter P Toth, et al.
The New England Journal of Medicine|August 25, 2023
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and ObesityMikhail N Kosiborod, Steen Z Abildstrøm, Barry A Borlaug, et al.
Lancet (London, England)|April 10, 2024
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trialsJaved Butler, Sanjiv J Shah, Mark C Petrie, et al.
European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.
The New England Journal of Medicine|April 8, 2024
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 DiabetesMikhail N Kosiborod, Mark C Petrie, Barry A Borlaug, et al.
Pageof 34